Abstract
Diagnosing disease at the molecular level rapidly and with a high level of sensitivity and specificity is a critical capability for modern medicine. Rapid detection of small numbers of biomarkers of early disease in complex, heterogeneous clinical specimens represents a Holy Grail that will have a significant impact on human health.
Original language | English (US) |
---|---|
Pages (from-to) | 503-507 |
Number of pages | 5 |
Journal | Accounts of chemical research |
Volume | 50 |
Issue number | 3 |
DOIs | |
State | Published - Mar 21 2017 |
Externally published | Yes |
ASJC Scopus subject areas
- Chemistry(all)